Drug prescribing pattern and clinical outcome in intensive care unit of a Dedicated COVID Hospital: A retrospective observational study
National Journal of Physiology, Pharmacy and Pharmacology
; 12(4):472-476, 2022.
Article
in English
| ProQuest Central | ID: covidwho-1789609
ABSTRACT
India currently holds the single-day record for the largest increase in cases, set on September 17, with an additional 97,894.pi Pandemic saw multiple of advisories being released by various governments in rapid succession The Coronavirus Treatment Acceleration Program, special emergency program for possible coronavirus therapies was launched by FDA, for accelerated development of treatment option for combating COVID-19 infection. [4] Various drug treatment protocols using drugs such as Vitamin C, hydroxychloroquine, Remdesivir, Tocilizumab, Favipiravir, and Interferons were recommended by governments across globe. [...]the present study aims to assess Drug Prescribing Pattern and Clinical Outcomes in Intensive Care Unit (ICU) of a Dedicated COVID Hospital. DISCUSSION The pandemic COVID-19 continues to be a significant problem worldwide. [...]the significant differences in clinical pattern coupled with coinciding chronological sequence poses agiant task for clinicians to choose appropriate treatment for optimal outcomes.
Pharmacy And Pharmacology; Infections; Infectious diseases; Medical records; Diabetes; Severe acute respiratory syndrome coronavirus 2; Demographics; Antibiotics; Steroids; Pandemics; Hypertension; Cardiovascular disease; Hospitals; Morbidity; Age groups; Illnesses; Prescription drugs; Coronaviruses; Intensive care; Males; Medical schools; Clinical outcomes; Disease transmission; COVID-19; United States--US; India
Full text:
Available
Collection:
Databases of international organizations
Database:
ProQuest Central
Type of study:
Observational study
/
Prognostic study
Language:
English
Journal:
National Journal of Physiology, Pharmacy and Pharmacology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS